Sharon Bio-Medicine Limited reported unaudited earnings results for the third quarter and nine months ended December 31, 2019. For the quarter, the company reported total revenue from operations of INR 392.838 million compared to INR 319.405 million a year ago. Net profit for the period after tax was INR 15.873 million compared to net loss for the period after tax of INR 0.338 million a year ago. Basic earnings per share was INR 0.13 against loss per share of INR 0.00 a year ago. For the nine months, the company reported total revenue from operations of INR 1,254.243 million. Net loss for the period after tax was INR 500.174 million. Basic loss per share was INR 1.80.